Results 161 to 170 of about 33,873 (301)
Full-Face Allograft Retrieval in a Multiple-Organ Donation in a Maastricht III Type Donor. [PDF]
Barret JP+4 more
europepmc +1 more source
Organ Transplantation: The Ethics of Consequences [PDF]
Weringer, Elora J.
core +1 more source
Lipidome changes in anthracycline‐induced cardiotoxicity (AIC). Aims Anthracyclines are key components of various chemotherapy regimens, but their clinical utility is limited by severe cardiotoxic side effects. Previous studies have suggested that anthracycline‐induced cardiotoxicity (AIC) may be driven by alterations in myocardial lipid metabolism ...
Vera M. Braun+6 more
wiley +1 more source
Impact of organ donation on grief symptoms in donor families. [PDF]
Latifi M+6 more
europepmc +1 more source
Quadruple-drug induction therapy in highly sensitized patients [PDF]
Abendroth, D.+3 more
core +1 more source
Long-term graft survival in a kidney transplant recipient with glioblastoma: Case report
Long-term immunosuppression after transplantation can increase the risk of cancer development in recipient patients. This case report describes the treatment approach for glioblastoma in a kidney transplant recipient after transplantation. The patient, a
Maryam Rahbar+5 more
doaj
Bioburden of postmortem bone tissues with a procurement time exceeding 36 h. [PDF]
Braun C+4 more
europepmc +1 more source
NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy
Due to limitation of penetration therapy with first and second‐generation photodynamic therapy (PDT) photosensitizers, an NIR II‐guided photoactivatable complex was proposed via the self‐assembly of the photosensitive polymer PTSQ and the electrostatic adsorption of siPD‐L1 to enhance cancer immunotherapy.
Yuquan Zhang+10 more
wiley +1 more source